Cincinnati-Based Onconetix Sets Nov. 6 Date for One-for-Ten Reverse Stock Split
Onconetix, Inc., the Cincinnati-based biopharmaceutical company, announced on Monday, October 26, that its board of directors has approved a one-for-ten reverse stock split of its outstanding common stock, effective at…